06/16/2026 | Press release | Archived content
National patient survey finds cost confusion, prior authorization delays can derail care, but technology can unlock price transparency, improve access
Arlington, Va. - June 16, 2026 - Surescripts®, the nation's leading health intelligence network, released a new report with the results of a national survey of 1,007 U.S. adults conducted by The Harris Poll, revealing that more than half (56%) of patients experience challenges when accessing prescriptions, citing cost, delays and prior authorizations as significant barriers.
Notably, 36% of patients indicated that getting clearer cost information before picking up a prescription would make navigating prescription costs easier.
Report: How Patient Access Technology Can Simplify the Patient Care Journey
"Patient access to prescription therapies is much harder than it should be-and too often that means going without medication therapies," said Frank Harvey, Chief Executive Officer for Surescripts. "The encouraging news is that patients want to work with their prescribers to understand their medication treatment options before arriving at the pharmacy. We're working to equip care providers with technology that enables them to help patients access more affordable medications without unnecessary delays."
"This survey reveals what we've known anecdotally: the path from prescription to therapy is too often slowed by unclear costs, fragmented support and disconnected systems-with real consequences for patients' health," said Matt Koehler, Chief Product Officer for Surescripts. "When clinicians are equipped with the right technology, they can help patients access treatment faster, close gaps and keep patient care on track."
Surescripts technology is improving patient prescription access, according to a recent report:
Surescripts partnered with The Harris Poll to conduct an online survey, in English and Spanish, of 1,007 U.S. patients between November 21 and December 1, 2025. Participants were U.S. residents aged 18 or older who had interacted with the U.S. healthcare system in the past 12 months. Results are accurate to within ± 4.0 percentage points at a 95% confidence level.